• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Bioventus LLC

Bioventus triggers $50M option to acquire CartiHeal

August 30, 2021 By Sean Whooley

Bioventus (NSDQ:BVS) announced today that it chose to make a $50 million escrow payment to acquire CartiHeal and its Agili-C implant. Durham, N.C.-based Bioventus elected to make its escrow payment pursuant to its option and equity purchase agreement with CartiHeal to signal its intent to move forward with an acquisition of the company. According to […]

Filed Under: Business/Financial News, Featured, Implants, Mergers & Acquisitions, Orthopedics Tagged With: Bioventus LLC, CartiHeal Ltd.

Bioventus posts Street-beating Q2, raises guidance

August 11, 2021 By Sean Whooley

Bioventus (NSDQ:BVS) shares ticked up before hours on second-quarter results that beat the consensus forecast. The Durham, N.C.-based ortho tech company posted losses of -$10.8 million, or -10¢ per share, on sales of $109.8 million for the three months ended July 3, 2021, for a -80.3% bottom-line slide on sales growth of 89.3%. Adjusted to […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Orthopedics, Wall Street Beat Tagged With: Bioventus LLC

Bioventus up on Street-beating Q4

March 29, 2021 By Sean Whooley

Bioventus (NSDQ:BVS) shares ticked up on fourth-quarter results that topped the consensus forecast. The Durham, N.C.-based ortho tech company posted profits of $2.3 million, or 10¢ per share, on sales of $98.6 million for the three months ended Dec. 31, 2020, for a 56% bottom-line slide on sales growth of 1.1%. Adjusted to exclude one-time […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Orthopedics, Wall Street Beat Tagged With: Bioventus LLC

Ortho tech company Bioventus launches IPO

February 4, 2021 By Chris Newmarker

Bioventus today announced the commencement of its initial public offering, selling 7.35 million shares of Class A common stock at $16–18 per share, which could fetch the company roughly $118–132 million. The shares are expected to trade on the Nasdaq Global Select Market under the ticker symbol “BVS.” The offering will be made only by […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Orthopedics Tagged With: Bioventus LLC

Bioventus names new CEO

March 26, 2020 By Danielle Kirsh

Bioventus this week said it appointed Ken Reali as CEO, effective April 20. Reali will replace Tony Biel who is retiring on April 30. “I am honored to have the opportunity to lead Bioventus,” Reali said in a news release. “The company’s broad product portfolio, global presence and solid growth have it well-positioned to serve […]

Filed Under: Business/Financial News Tagged With: Bioventus LLC

Bioventus launches Osteomatrix+ bone graft

January 17, 2019 By Chris Newmarker

Bioventus announced today that it has started selling Osteomatrix+ – a moldable bone graft substitute intended for a variety of orthopedic and spine bone remodeling applications. Bioventus officials boast that Osteomatrix+ has improved moldability, flexibility and versatility versus its predecessor. “Osteomatrix+ represents the first of several next-generation products that will be added to the Bioventus portfolio […]

Filed Under: Business/Financial News, News Well, Orthopedics Tagged With: Bioventus LLC

Bioventus to deal Pfizer bone protein program to PE shop

July 23, 2018 By Brad Perriello

Bioventus said today that it agreed to sell the bone morphogenetic protein technology it licensed from Pfizer (NYSE:PFE) to private equity shop that specializes in the orthopedics industry for an undisclosed amount. Created in a 2012 spinout worth $367 million from Smith & Nephew (FTSE:SN, NYSE:SNN), Bioventus in 2013 inked a deal with Pfizer to develop a next-generation BMP product. In October 2014 […]

Filed Under: Mergers & Acquisitions, Orthopedics, Regenerative Medicine, Wall Street Beat Tagged With: Bioventus LLC, Viscogliosi Bros.

7 medtech stories we missed this week: Sept. 22, 2017

September 22, 2017 By Danielle Kirsh

From the FDA’s clearance of Covalon’s film-drape to Bioventus launching its study, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Covalon’s MediClear OTC surgical film-drape Covalon announced in a Sept. 21 press release that the FDA has cleared its MediClear PreOp to market in U.S. hospitals, […]

Filed Under: Business/Financial News, Diagnostics, Digital Health, Food & Drug Administration (FDA), Lab Instruments & Supplies, Research & Development, Vascular Tagged With: Bioventus LLC, Contego Medical, Covalon Technologies, Getinge, Guerbet, IBA, ManaMed, Medovex, MedTech

Bioventus wins FDA nod for knee osteoarthritis pain injection

September 5, 2017 By Sarah Faulkner

Bioventus said today that its Durolane single-injection, hyaluronic acid product won FDA approval for the treatment of pain associated with knee osteoarthritis. When a person develops osteoarthritis in their knee, the cartilage breaks down and so does the synovial fluid that provides lubrication to joint tissues. Hyaluronic acid provides cushioning and lubrication to the knee, […]

Filed Under: Food & Drug Administration (FDA), Orthopedics, Pharmaceutical, Regulatory/Compliance Tagged With: Bioventus LLC

Bioventus wins FDA nod for Durolane OA joint lubrication product

September 5, 2017 By Fink Densford

Bioventus said today it won FDA approval for its Durolane injectable product designed for joint lubrication and treating pain associated with knee osteoarthritis. Durolane is a single-injection, hyaluornic acid product designed to lubricate joints to treat pain associated with knee osteoarthritis, Durham, N.C.-based Bioventus said. The company acquired it last December from Galderma for an undisclosed amount. […]

Filed Under: Food & Drug Administration (FDA), Orthopedics, Pain Management, Regulatory/Compliance Tagged With: Bioventus LLC

NuVasive taps new CFO | Personnel Moves – August 15, 2017

August 15, 2017 By Brad Perriello

NuVasive Inc. (NSDQ:NUVA) said today that it tapped Rajesh Asarpota to be its new CFO effective Sept. 1, replacing Quentin Blackford, who jumped ship last month for the top finance spot at Dexcom Inc. (NSDQ:DXCM). San Diego-based NuVasive said Asarpota began his career at GE Healthcare (NYSE:GE)before moving to Life Technologies (NSDQ:LIFE), Questcor Pharmaceuticals and “private equity-backed healthcare […]

Filed Under: Wall Street Beat Tagged With: Bioventus LLC, Endologix, Nuvasive, Personnel Moves

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS